Learning and Development for Innovation and Resilience in The Pharmaceutical Industry

In the pharmaceutical industry, learning and development (L&D) has evolved from a compliance-oriented training function to a strategic enabler of workforce competitiveness, innovation, and ‎organizational resilience in recent years. However, research on L&D in the pharmaceutical industry ‎remains fragmented and requires a systematic synthesis. A systematic literature review (SLR) was ‎conducted following the PRISMA 2020 guidelines. Using predefined search strings in Scopus, peer-reviewed journal articles from 2015 to 2025 in Business and Economics were retrieved, and 1,769 ‎records were screened, resulting in 58 studies being included in the review. Publication trends, leading ‎journals, geographical distribution, and themes of the literature were examined using descriptive and ‎thematic analyses. While there was an increase in publications in the literature, most were published ‎between 2021 and 2023, likely due to the increased focus on upskilling the workforce and digital ‎transformation during the COVID-19 pandemic. The leading journals were the Journal of Business ‎Research, Human Resource Development International, and Management Decision, and research was ‎concentrated in the United States, Europe, India, and China, with little evidence of collaborative ‎networks among them. The dominant themes included digital training, leadership development, ‎regulatory learning, and workforce reskilling, and the conceptual frameworks included the Knowledge-Based View and Human Capital Theory, although few were tailored to the pharmaceutical industry’s ‎regulatory context. The study outcomes emphasized enhancements in employee performance, ‎innovation capacity, compliance, and organizational growth. This review suggests that L&D is a ‎strategic imperative in the pharmaceutical industry and can drive competitiveness. However, gaps exist, ‎particularly in longitudinal studies, AI-driven learning evaluations, and research on emerging ‎economies‎.

Authors

Institutions

Publication Details

Journal
International Journal of Accounting and Economics Studies
Published
2025-12-07
DOI
https://doi.org/10.14419/bjsjp624
Primary Topic
The Impact of Diversity and Innovation on Society
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Learning and Development for Innovation and Resilience in The Pharmaceutical Industry

Suresh Sirisetti, Ms. Uma Sundari U
International Journal of Accounting and Economics Studies
The Impact of Diversity and Innovation on Society
article

Learning and Development for Innovation and Resilience in The Pharmaceutical Industry

Suresh Sirisetti, Ms. Uma Sundari U
article en

Abstract

In the pharmaceutical industry, learning and development (L&D) has evolved from a compliance-oriented training function to a strategic enabler of workforce competitiveness, innovation, and ‎organizational resilience in recent years. However, research on L&D in the pharmaceutical industry ‎remains fragmented and requires a systematic synthesis. A systematic literature review (SLR) was ‎conducted following the PRISMA 2020 guidelines. Using predefined search strings in Scopus, peer-reviewed journal articles from 2015 to 2025 in Business and Economics were retrieved, and 1,769 ‎records were screened, resulting in 58 studies being included in the review. Publication trends, leading ‎journals, geographical distribution, and themes of the literature were examined using descriptive and ‎thematic analyses. While there was an increase in publications in the literature, most were published ‎between 2021 and 2023, likely due to the increased focus on upskilling the workforce and digital ‎transformation during the COVID-19 pandemic. The leading journals were the Journal of Business ‎Research, Human Resource Development International, and Management Decision, and research was ‎concentrated in the United States, Europe, India, and China, with little evidence of collaborative ‎networks among them. The dominant themes included digital training, leadership development, ‎regulatory learning, and workforce reskilling, and the conceptual frameworks included the Knowledge-Based View and Human Capital Theory, although few were tailored to the pharmaceutical industry’s ‎regulatory context. The study outcomes emphasized enhancements in employee performance, ‎innovation capacity, compliance, and organizational growth. This review suggests that L&D is a ‎strategic imperative in the pharmaceutical industry and can drive competitiveness. However, gaps exist, ‎particularly in longitudinal studies, AI-driven learning evaluations, and research on emerging ‎economies‎.

International Journal of Accounting and Economics StudiesVol. 12(8)
GITAM University (IN)
Openalex Percentile: Top 52%
The Impact of Diversity and Innovation on Society
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Learning and Development for Innovation and Resilience in The Pharmaceutical Industry — Suresh Sirisetti, Ms. Uma Sundari U · International Journal of Accounting and Economics Studies (2025) | TGRS Research Map | TGRS